Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Inventory (2024 - 2025)

Insight Molecular Diagnostics' Inventory history spans 2 years, with the latest figure at $471000.0 for Q3 2025.

  • For Q3 2025, Inventory rose 103.02% year-over-year to $471000.0; the TTM value through Sep 2025 reached $471000.0, up 103.02%, while the annual FY2024 figure was $410000.0, N/A changed from the prior year.
  • Inventory for Q3 2025 was $471000.0 at Insight Molecular Diagnostics, down from $693000.0 in the prior quarter.
  • Across five years, Inventory topped out at $693000.0 in Q2 2025 and bottomed at $232000.0 in Q3 2024.